Global Chronic Disease Management Market Size, Share & Industry Trends Analysis Report By Type (Solutions and Services), By End User (Healthcare Providers, Healthcare Payers and Others), By Disease Type, By Regional Outlook and Forecast, 2022

List of Tables

The Global Chronic Disease Management Market size is expected to reach $9.9 billion by 2028, rising at a market growth of 11.7% CAGR during the forecast period.

The treatment of chronic diseases is managed by an integrated care strategy that involves patient education, screenings, checkups, monitoring, and coordination of care. While lowering healthcare expenses, it can raise life quality. An ailment that lasts for a year or longer, necessitates continuing medical care, and/or restricts a person's everyday activities is often referred to as a chronic disease.

Heart disease, chronic respiratory diseases, high blood pressure, diabetes, stroke, asthma, and cancer are a few of the most prevalent chronic illnesses. Metabolic and behavioural risk factors are the two primary risks linked to chronic disease. In contrast to the metabolic risk factors, which include obesity, hyperglycemia, and high blood pressure, the behavioural risk factor includes the use of tobacco, inactivity, unhealthy eating, and problematic alcohol use.

The increase in the elderly population and the rise in the prevalence of numerous chronic diseases, such as cancer and others, are the main drivers of the chronic disease management market's expansion. For example, as per the NCBI, 43 percent of all diseases and 60 percent of deaths worldwide are caused by chronic conditions. Additionally, non-communicable diseases impact people of all ages, geographical areas, and nations, according to the WHO (NCDs).

Additionally, the growth of the Chronic Disease Management Market is driven by the rise in acceptance of chronic disease management as a result of the incorporation of IT solutions. To help people effectively manage their disease, a variety of initiatives have been developed by healthcare professionals, organizations, and payers. Such initiatives, in contrast to conventional patient education, place a stronger emphasis on problem-solving as well as social coping strategies in order to increase self-efficacy in the field of care management.

COVID-19 Impact Analysis

The market for managing chronic diseases continues to benefit from COVID-19's overall effects. The rising incidence of COVID-19 has increased the requirement for precise diagnostic and therapeutic tools in a number of nations. The ability of healthcare providers to easily connect solutions like patient management, EHR, and care management with healthcare payer solutions like claim management & payment management has shown to be quite beneficial in this regard. Additionally, the disease's quick global spread has led to lockdowns and other limitations, which has raised the demand for electronic data transfer & claim administration. In the upcoming years, it is anticipated that this will enhance the popularity of chronic disease management.

Market Growth Factors

Rising Cases Of Various Chronic Diseases

During the forecast period, the incidence of chronic diseases like diabetes, cancer, high blood pressure, and others would increase, boosting the market's growth rate. Given that older people are more likely to be obese and have diabetes, chronic diseases are a significant source of worry for them. Numerous patients undergoing chronic disease management face socioeconomic obstacles that make it challenging for them to routinely obtain and pay for healthcare treatments. If these patients lack the necessary funds, they may postpone or forego necessary therapy.

Growing Number Of Geriatric Population

Because life expectancy has increased over time, there are steadily more people in their 60s and older. As per the United Nations Database on World Population Ageing 2020, that there will be 1.5 billion elderly people worldwide by 2050, up from 727 million in 2020. The danger of developing chronic diseases is higher in the elderly, which drives up demand for the chronic disease management market. Since older population are more prone to various disease, particularly chronic ones, companies are majorly aiming at the introduction of advanced and improved solutions in the market.

Market Restraining Factors

Lack Of Proper Communication In Chronic Care Management

Delivering high-quality patient care depends on effective communication, which is also the cornerstone of provider-patient interactions. Providers are better able to offer the proper treatment when patients feel understood and heard. Long after the appointment has ended, the same patients are more willing to follow the recommended treatment strategies. The pandemic caused a profound change in patient expectations and behaviour.

Disease Type Outlook

Based on disease type, the chronic disease management market is segmented into Cardiovascular diseases, Diabetes, Cancer, Asthma, Chronic obstructive pulmonary disorders, and Others. The cancer segment witnessed a promising revenue share in the chronic disease management market in 2021. It is owing to the growing cases of various types of cancers among individuals. Typically, cancer types are called for the organs or tissues in which they first appear.

Type Outlook

On the basis of type, the chronic disease management market is bifurcated into Solutions and Services. The solutions segment acquired the highest revenue share in the chronic disease management market in 2021. The expansion of the chronic illness management system and the market are driven by the increased awareness of the utilization of cloud-based and on-premise solutions in healthcare.

End-User Outlook

By end-user, the chronic disease management market is classified into Healthcare Providers, Healthcare Payers and Others. Healthcare Payers segment procured a significant revenue share in the chronic disease management market in 2021. The market is expanding as a result of the increase in geriatric population and the incidence of chronic diseases. Organizations that determine service prices, process claims, collect payments, and pay provider claims include payers in the health care sector like Medicare, health plan providers, and Medicaid.

Regional Outlook

Region-wise, the chronic disease management market is analyzed across North America, Europe, Asia Pacific and LAMEA. North America emerged the leading region in the chronic disease management market with the highest revenue share in 2021. This is explained by an increase in chronic disease occurrences, the presence of important figures, and improvements in healthcare in the area. For instance, six out of ten Americans have at least one chronic illness, such as diabetes, cancer, heart disease, or a stroke, all of which are major contributors to this country's rising healthcare expenses and are major causes of mortality and disability.

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; ExlService Holdings, Inc. is the major forerunner in the Chronic Disease Management Market. Companies such as Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc. and Koninklijke Philips N.V. are some of the key innovators in Chronic Disease Management Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.

Recent strategies deployed in Chronic Disease Management Market

Product Launches and Product Expansions:

May-2022: Koninklijke Philips introduced various new innovative additions to its prevailing healthcare solutions portfolio. These additions involve ultra-low contrast percutaneous coronary intervention (ULC-PCI), EchoNavigator 2.0, Dynamic Coronary Roadmap Software, iFR Co-registration, and IVUS Co-registration. ULC-PCI would assist interventionists to perform percutaneous coronary intervention with more confidence and clarity and at a much more decreased cost, EchoNavigator 4.0 would help in complicated heart disease treatment like heart valve repair or therapy.

Oct-2021: EXL launched a new omnichannel Patient Engagement Platform. This platform utilizes real-world patient information and powerful analytics to boost highly customized care management programs for health plans and self-insured employers.

Aug-2021: Casenet unveiled the TruCare care management solution integrated with clinical solutions for telehealth and remote patient monitoring (RPM) on the ZyterHealth platform. This integration of clinical data and care management data on the ZyterHealth platform would complement the objectives of value-based care programs by delivering providers and payers a more holistic view of both the medical issues and social problems affecting the patient's healthcare experience.

Nov-2020: Royal Philips launched a non-invasive Philips Ventilator BiPAP A40 EFL. The new device would assist pulmonologists to identify COPD patients with expiratory flow limitation (EFL) and treat them with targeted therapy to reduce symptoms and provide better comfort during sleep.

Sep-2020: Casenet introduced Zyter Home Health and Remote Patient Monitoring (RPM). This product is a complete, ready-to-implement solution that would expand healthcare and monitoring beyond the conventional environment, which would make it simpler for patients to participate in their own care and actively handle their conditions.

Jun-2020: Health Catalyst released comprehensive quality measures solution that would integrate its Data Operating System with the application of a scalable measure. This solution is developed to enhance provider quality measurement. To offer customers one comprehensive quality performance system by integrating comprehensive data from DOS with complete measures, visualizations, and workflows into one product.

Acquisitions and Mergers:

Dec-2021: Royal Philips acquired Vesper Medical, a medical technology company. This acquisition aimed to enable Philips to expand its diagnostic as well as therapeutic device portfolio with an improved venous stent portfolio to cure deep venous disease.

Nov-2021: Royal Philips took over Cardiologs, a France-based medical technology company. This acquisition aimed to complement Philips' prevailing portfolio of cardiac care solutions. This involves real-time patient monitoring, telehealth, therapeutic devices, and informatics for the hospital.

Oct-2021: Altruista Health acquired Wellframe, a digital health management company. This acquisition aimed to boost HealthEdge's portfolio of SaaS solutions over payer workflow operations and would mark HealthEdge's entry into member engagement.

Jan-2021: Cedar Gate Technologies took over Enli Health Intelligence, a provider of population health management technology solutions. This acquisition aimed to expand Cedar Gate's enterprise value-based care platform with the cohort, population, and patient management technologies, incorporating risk & quality measures, gaps in care identification, and patient outreach opportunities, for better results and sustainable financial outcomes.

Dec-2020: Philips took over BioTelemetry, a leading provider of remote cardiac diagnostics and monitoring. This acquisition aimed to strengthen Philips's offering of remote care products. Along with that, the acquisition would complement Philips' cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with combined solutions.

Partnerships, Collaborations and Agreements:

Aug-2022: Health Catalyst joined hands with LifePoint Health, an American company that provides healthcare services. This collaboration aimed to improve patient care and enhance results across the health system's network. In this collaboration, LifePoint Health would deploy Health Catalyst's suite of patient care solutions, involving a range of data collection and analytics platforms.

Mar-2022: Cognizant, the parent company of TriZetto Software Group collaborated with Microsoft, an American multinational technology corporation. This collaboration aimed to improve remote patient monitoring for improved medical care. Using data analytics, safe cloud technology, and interoperability products, this collaboration would deliver a unique, scalable solution that would focus to connect providers & patients and improve the timeliness, quality, and personalization of healthcare.

Approvals and Trials:

Mar-2022: Royal Philips got approval for the Philips Capsule Surveillance solution from the U.S. Food & Drug Administration (FDA). This FDA clearance of the new release of clinical surveillance solution would allow more integrated viewing options under EMR and HIT tools via the safe web-based customer interface.

Nov-2021: Royal Philips got 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Liver Fat Quantification tools. This release of ultrasound systems EPIQ Elite and Affiniti would bring the cost and accessibility benefits of sonography to the diagnosis of early-stage liver disease.

Scope of the Study

Market Segments covered in the Report:

By Type

Solutions
Services

By End User

Healthcare Providers
Healthcare Payers
Others

By Disease Type

Diabetes
Cardiovascular diseases
Asthma
Chronic obstructive pulmonary disorders
Cancer
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Infosys Limited
ExlService Holdings, Inc.
Health Catalyst, Inc.
AllScripts Healthcare Solutions, Inc.
Koninklijke Philips N.V.
Cognizant Technology Solutions Corporation
Casenet, LLC
Cedar Gate Technologies
Clinical Excellence, Inc.
Altruista Health, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Chronic Disease Management Market, by Type
- 1.4.2 Global Chronic Disease Management Market, by End User
- 1.4.3 Global Chronic Disease Management Market, by Disease Type
- 1.4.4 Global Chronic Disease Management Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep - 2022, May) Leading Players

Chapter 4. Global Chronic Disease Management Market by Type

4.1 Global Solutions Market by Region
4.2 Global Services Market by Region

Chapter 5. Global Chronic Disease Management Market by End User

5.1 Global Healthcare Providers Market by Region
5.2 Global Healthcare Payers Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Chronic Disease Management Market by Disease Type

6.1 Global Diabetes Market by Region
6.2 Global Cardiovascular diseases Market by Region
6.3 Global Asthma Market by Region
6.4 Global Chronic obstructive pulmonary disorders Market by Region
6.5 Global Cancer Market by Region
6.6 Global Others Market by Region

Chapter 7. Global Chronic Disease Management Market by Region

7.1 North America Chronic Disease Management Market
- 7.1.1 North America Chronic Disease Management Market by Type
  - 7.1.1.1 North America Solutions Market by Country
  - 7.1.1.2 North America Services Market by Country
- 7.1.2 North America Chronic Disease Management Market by End User
  - 7.1.2.1 North America Healthcare Providers Market by Country
  - 7.1.2.2 North America Healthcare Payers Market by Country
  - 7.1.2.3 North America Others Market by Country
- 7.1.3 North America Chronic Disease Management Market by Disease Type
  - 7.1.3.1 North America Diabetes Market by Country
  - 7.1.3.2 North America Cardiovascular diseases Market by Country
  - 7.1.3.3 North America Asthma Market by Country
  - 7.1.3.4 North America Chronic obstructive pulmonary disorders Market by Country
  - 7.1.3.5 North America Cancer Market by Country
  - 7.1.3.6 North America Others Market by Country
- 7.1.4 North America Chronic Disease Management Market by Country
  - 7.1.4.1 US Chronic Disease Management Market
    - 7.1.4.1.1 US Chronic Disease Management Market by Type
    - 7.1.4.1.2 US Chronic Disease Management Market by End User
    - 7.1.4.1.3 US Chronic Disease Management Market by Disease Type
  - 7.1.4.2 Canada Chronic Disease Management Market
    - 7.1.4.2.1 Canada Chronic Disease Management Market by Type
    - 7.1.4.2.2 Canada Chronic Disease Management Market by End User
    - 7.1.4.2.3 Canada Chronic Disease Management Market by Disease Type
  - 7.1.4.3 Mexico Chronic Disease Management Market
    - 7.1.4.3.1 Mexico Chronic Disease Management Market by Type
    - 7.1.4.3.2 Mexico Chronic Disease Management Market by End User
    - 7.1.4.3.3 Mexico Chronic Disease Management Market by Disease Type
  - 7.1.4.4 Rest of North America Chronic Disease Management Market
    - 7.1.4.4.1 Rest of North America Chronic Disease Management Market by Type
    - 7.1.4.4.2 Rest of North America Chronic Disease Management Market by End User
    - 7.1.4.4.3 Rest of North America Chronic Disease Management Market by Disease Type
7.2 Europe Chronic Disease Management Market
- 7.2.1 Europe Chronic Disease Management Market by Type
  - 7.2.1.1 Europe Solutions Market by Country
  - 7.2.1.2 Europe Services Market by Country
- 7.2.2 Europe Chronic Disease Management Market by End User
  - 7.2.2.1 Europe Healthcare Providers Market by Country
  - 7.2.2.2 Europe Healthcare Payers Market by Country
  - 7.2.2.3 Europe Others Market by Country
- 7.2.3 Europe Chronic Disease Management Market by Disease Type
  - 7.2.3.1 Europe Diabetes Market by Country
  - 7.2.3.2 Europe Cardiovascular diseases Market by Country
  - 7.2.3.3 Europe Asthma Market by Country
  - 7.2.3.4 Europe Chronic obstructive pulmonary disorders Market by Country
  - 7.2.3.5 Europe Cancer Market by Country
  - 7.2.3.6 Europe Others Market by Country
- 7.2.4 Europe Chronic Disease Management Market by Country
  - 7.2.4.1 Germany Chronic Disease Management Market
    - 7.2.4.1.1 Germany Chronic Disease Management Market by Type
    - 7.2.4.1.2 Germany Chronic Disease Management Market by End User
    - 7.2.4.1.3 Germany Chronic Disease Management Market by Disease Type
  - 7.2.4.2 UK Chronic Disease Management Market
    - 7.2.4.2.1 UK Chronic Disease Management Market by Type
    - 7.2.4.2.2 UK Chronic Disease Management Market by End User
    - 7.2.4.2.3 UK Chronic Disease Management Market by Disease Type
  - 7.2.4.3 France Chronic Disease Management Market
    - 7.2.4.3.1 France Chronic Disease Management Market by Type
    - 7.2.4.3.2 France Chronic Disease Management Market by End User
    - 7.2.4.3.3 France Chronic Disease Management Market by Disease Type
  - 7.2.4.4 Russia Chronic Disease Management Market
    - 7.2.4.4.1 Russia Chronic Disease Management Market by Type
    - 7.2.4.4.2 Russia Chronic Disease Management Market by End User
    - 7.2.4.4.3 Russia Chronic Disease Management Market by Disease Type
  - 7.2.4.5 Spain Chronic Disease Management Market
    - 7.2.4.5.1 Spain Chronic Disease Management Market by Type
    - 7.2.4.5.2 Spain Chronic Disease Management Market by End User
    - 7.2.4.5.3 Spain Chronic Disease Management Market by Disease Type
  - 7.2.4.6 Italy Chronic Disease Management Market
    - 7.2.4.6.1 Italy Chronic Disease Management Market by Type
    - 7.2.4.6.2 Italy Chronic Disease Management Market by End User
    - 7.2.4.6.3 Italy Chronic Disease Management Market by Disease Type
  - 7.2.4.7 Rest of Europe Chronic Disease Management Market
    - 7.2.4.7.1 Rest of Europe Chronic Disease Management Market by Type
    - 7.2.4.7.2 Rest of Europe Chronic Disease Management Market by End User
    - 7.2.4.7.3 Rest of Europe Chronic Disease Management Market by Disease Type
7.3 Asia Pacific Chronic Disease Management Market
- 7.3.1 Asia Pacific Chronic Disease Management Market by Type
  - 7.3.1.1 Asia Pacific Solutions Market by Country
  - 7.3.1.2 Asia Pacific Services Market by Country
- 7.3.2 Asia Pacific Chronic Disease Management Market by End User
  - 7.3.2.1 Asia Pacific Healthcare Providers Market by Country
  - 7.3.2.2 Asia Pacific Healthcare Payers Market by Country
  - 7.3.2.3 Asia Pacific Others Market by Country
- 7.3.3 Asia Pacific Chronic Disease Management Market by Disease Type
  - 7.3.3.1 Asia Pacific Diabetes Market by Country
  - 7.3.3.2 Asia Pacific Cardiovascular diseases Market by Country
  - 7.3.3.3 Asia Pacific Asthma Market by Country
  - 7.3.3.4 Asia Pacific Chronic obstructive pulmonary disorders Market by Country
  - 7.3.3.5 Asia Pacific Cancer Market by Country
  - 7.3.3.6 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific Chronic Disease Management Market by Country
  - 7.3.4.1 China Chronic Disease Management Market
    - 7.3.4.1.1 China Chronic Disease Management Market by Type
    - 7.3.4.1.2 China Chronic Disease Management Market by End User
    - 7.3.4.1.3 China Chronic Disease Management Market by Disease Type
  - 7.3.4.2 Japan Chronic Disease Management Market
    - 7.3.4.2.1 Japan Chronic Disease Management Market by Type
    - 7.3.4.2.2 Japan Chronic Disease Management Market by End User
    - 7.3.4.2.3 Japan Chronic Disease Management Market by Disease Type
  - 7.3.4.3 India Chronic Disease Management Market
    - 7.3.4.3.1 India Chronic Disease Management Market by Type
    - 7.3.4.3.2 India Chronic Disease Management Market by End User
    - 7.3.4.3.3 India Chronic Disease Management Market by Disease Type
  - 7.3.4.4 South Korea Chronic Disease Management Market
    - 7.3.4.4.1 South Korea Chronic Disease Management Market by Type
    - 7.3.4.4.2 South Korea Chronic Disease Management Market by End User
    - 7.3.4.4.3 South Korea Chronic Disease Management Market by Disease Type
  - 7.3.4.5 Singapore Chronic Disease Management Market
    - 7.3.4.5.1 Singapore Chronic Disease Management Market by Type
    - 7.3.4.5.2 Singapore Chronic Disease Management Market by End User
    - 7.3.4.5.3 Singapore Chronic Disease Management Market by Disease Type
  - 7.3.4.6 Malaysia Chronic Disease Management Market
    - 7.3.4.6.1 Malaysia Chronic Disease Management Market by Type
    - 7.3.4.6.2 Malaysia Chronic Disease Management Market by End User
    - 7.3.4.6.3 Malaysia Chronic Disease Management Market by Disease Type
  - 7.3.4.7 Rest of Asia Pacific Chronic Disease Management Market
    - 7.3.4.7.1 Rest of Asia Pacific Chronic Disease Management Market by Type
    - 7.3.4.7.2 Rest of Asia Pacific Chronic Disease Management Market by End User
    - 7.3.4.7.3 Rest of Asia Pacific Chronic Disease Management Market by Disease Type
7.4 LAMEA Chronic Disease Management Market
- 7.4.1 LAMEA Chronic Disease Management Market by Type
  - 7.4.1.1 LAMEA Solutions Market by Country
  - 7.4.1.2 LAMEA Services Market by Country
- 7.4.2 LAMEA Chronic Disease Management Market by End User
  - 7.4.2.1 LAMEA Healthcare Providers Market by Country
  - 7.4.2.2 LAMEA Healthcare Payers Market by Country
  - 7.4.2.3 LAMEA Others Market by Country
- 7.4.3 LAMEA Chronic Disease Management Market by Disease Type
  - 7.4.3.1 LAMEA Diabetes Market by Country
  - 7.4.3.2 LAMEA Cardiovascular diseases Market by Country
  - 7.4.3.3 LAMEA Asthma Market by Country
  - 7.4.3.4 LAMEA Chronic obstructive pulmonary disorders Market by Country
  - 7.4.3.5 LAMEA Cancer Market by Country
  - 7.4.3.6 LAMEA Others Market by Country
- 7.4.4 LAMEA Chronic Disease Management Market by Country
  - 7.4.4.1 Brazil Chronic Disease Management Market
    - 7.4.4.1.1 Brazil Chronic Disease Management Market by Type
    - 7.4.4.1.2 Brazil Chronic Disease Management Market by End User
    - 7.4.4.1.3 Brazil Chronic Disease Management Market by Disease Type
  - 7.4.4.2 Argentina Chronic Disease Management Market
    - 7.4.4.2.1 Argentina Chronic Disease Management Market by Type
    - 7.4.4.2.2 Argentina Chronic Disease Management Market by End User
    - 7.4.4.2.3 Argentina Chronic Disease Management Market by Disease Type
  - 7.4.4.3 UAE Chronic Disease Management Market
    - 7.4.4.3.1 UAE Chronic Disease Management Market by Type
    - 7.4.4.3.2 UAE Chronic Disease Management Market by End User
    - 7.4.4.3.3 UAE Chronic Disease Management Market by Disease Type
  - 7.4.4.4 Saudi Arabia Chronic Disease Management Market
    - 7.4.4.4.1 Saudi Arabia Chronic Disease Management Market by Type
    - 7.4.4.4.2 Saudi Arabia Chronic Disease Management Market by End User
    - 7.4.4.4.3 Saudi Arabia Chronic Disease Management Market by Disease Type
  - 7.4.4.5 South Africa Chronic Disease Management Market
    - 7.4.4.5.1 South Africa Chronic Disease Management Market by Type
    - 7.4.4.5.2 South Africa Chronic Disease Management Market by End User
    - 7.4.4.5.3 South Africa Chronic Disease Management Market by Disease Type
  - 7.4.4.6 Nigeria Chronic Disease Management Market
    - 7.4.4.6.1 Nigeria Chronic Disease Management Market by Type
    - 7.4.4.6.2 Nigeria Chronic Disease Management Market by End User
    - 7.4.4.6.3 Nigeria Chronic Disease Management Market by Disease Type
  - 7.4.4.7 Rest of LAMEA Chronic Disease Management Market
    - 7.4.4.7.1 Rest of LAMEA Chronic Disease Management Market by Type
    - 7.4.4.7.2 Rest of LAMEA Chronic Disease Management Market by End User
    - 7.4.4.7.3 Rest of LAMEA Chronic Disease Management Market by Disease Type

Chapter 8. Company Profiles

8.1 Infosys Limited
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 Recent strategies and developments:
  - 8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Partnerships, Collaborations, and Agreements:
  - 8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional & Segmental Analysis
- 8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Partnerships, Collaborations, and Agreements:
  - 8.5.5.2 Product Launches and Product Expansions:
  - 8.5.5.3 Acquisition and Mergers:
  - 8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
- 8.6.1 Company overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Recent strategies and developments:
  - 8.6.4.1 Partnerships, Collaborations, and Agreements:
- 8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
- 8.7.1 Company Overview
- 8.7.2 Recent strategies and developments:
  - 8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
- 8.8.1 Company Overview
- 8.8.2 Recent strategies and developments:
  - 8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
- 8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
- 8.10.1 Company Overview
- 8.10.2 Recent strategies and developments:
  - 8.10.2.1 Acquisition and Mergers:

LIST OF TABLES

TABLE 1 Global Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 2 Global Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements - Chronic Disease Management Market
TABLE 4 Product Launches And Product Expansions - Chronic Disease Management Market
TABLE 5 Acquisition and Mergers - Chronic Disease Management Market
TABLE 6 Approvals and Trials - Chronic Disease Management Market
TABLE 7 Global Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 8 Global Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 9 Global Solutions Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Solutions Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Services Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Services Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 14 Global Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 15 Global Healthcare Providers Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Healthcare Providers Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Healthcare Payers Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Healthcare Payers Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 22 Global Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 23 Global Diabetes Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Diabetes Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Cardiovascular diseases Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Cardiovascular diseases Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Asthma Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Asthma Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Chronic obstructive pulmonary disorders Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Chronic obstructive pulmonary disorders Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Cancer Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Cancer Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Chronic Disease Management Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Chronic Disease Management Market by Region, 2022 - 2028, USD Million
TABLE 37 North America Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 38 North America Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 39 North America Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 40 North America Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 41 North America Solutions Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Solutions Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Services Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Services Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 46 North America Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 47 North America Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 54 North America Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 55 North America Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Cardiovascular diseases Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Cardiovascular diseases Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Asthma Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Asthma Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Chronic obstructive pulmonary disorders Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Chronic obstructive pulmonary disorders Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Cancer Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Cancer Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Chronic Disease Management Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Chronic Disease Management Market by Country, 2022 - 2028, USD Million
TABLE 69 US Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 70 US Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 71 US Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 72 US Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 73 US Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 74 US Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 75 US Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 76 US Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 77 Canada Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 78 Canada Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 79 Canada Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 80 Canada Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 81 Canada Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 82 Canada Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 83 Canada Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 84 Canada Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 85 Mexico Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 86 Mexico Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 87 Mexico Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 88 Mexico Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 89 Mexico Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 90 Mexico Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 91 Mexico Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 92 Mexico Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 93 Rest of North America Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 94 Rest of North America Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 95 Rest of North America Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 96 Rest of North America Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 97 Rest of North America Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 98 Rest of North America Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 99 Rest of North America Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 100 Rest of North America Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 101 Europe Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 102 Europe Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 103 Europe Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 104 Europe Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 105 Europe Solutions Market by Country, 2018 - 2021, USD Million
TABLE 106 Europe Solutions Market by Country, 2022 - 2028, USD Million
TABLE 107 Europe Services Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Services Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 110 Europe Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 111 Europe Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 118 Europe Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 119 Europe Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Cardiovascular diseases Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Cardiovascular diseases Market by Country, 2022 - 2028, USD Million
TABLE 123 Europe Asthma Market by Country, 2018 - 2021, USD Million
TABLE 124 Europe Asthma Market by Country, 2022 - 2028, USD Million
TABLE 125 Europe Chronic obstructive pulmonary disorders Market by Country, 2018 - 2021, USD Million
TABLE 126 Europe Chronic obstructive pulmonary disorders Market by Country, 2022 - 2028, USD Million
TABLE 127 Europe Cancer Market by Country, 2018 - 2021, USD Million
TABLE 128 Europe Cancer Market by Country, 2022 - 2028, USD Million
TABLE 129 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 130 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 131 Europe Chronic Disease Management Market by Country, 2018 - 2021, USD Million
TABLE 132 Europe Chronic Disease Management Market by Country, 2022 - 2028, USD Million
TABLE 133 Germany Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 134 Germany Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 135 Germany Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 136 Germany Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 137 Germany Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 138 Germany Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 139 Germany Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 140 Germany Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 141 UK Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 142 UK Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 143 UK Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 144 UK Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 145 UK Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 146 UK Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 147 UK Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 148 UK Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 149 France Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 150 France Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 151 France Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 152 France Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 153 France Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 154 France Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 155 France Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 156 France Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 157 Russia Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 158 Russia Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 159 Russia Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 160 Russia Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 161 Russia Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 162 Russia Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 163 Russia Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 164 Russia Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 165 Spain Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 166 Spain Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 167 Spain Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 168 Spain Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 169 Spain Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 170 Spain Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 171 Spain Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 172 Spain Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 173 Italy Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 174 Italy Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 175 Italy Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 176 Italy Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 177 Italy Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 178 Italy Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 179 Italy Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 180 Italy Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 181 Rest of Europe Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 182 Rest of Europe Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 183 Rest of Europe Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 184 Rest of Europe Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 185 Rest of Europe Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 186 Rest of Europe Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 187 Rest of Europe Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 188 Asia Pacific Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 189 Asia Pacific Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 190 Asia Pacific Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 191 Asia Pacific Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 192 Asia Pacific Solutions Market by Country, 2018 - 2021, USD Million
TABLE 193 Asia Pacific Solutions Market by Country, 2022 - 2028, USD Million
TABLE 194 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
TABLE 195 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
TABLE 196 Asia Pacific Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 197 Asia Pacific Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 198 Asia Pacific Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 199 Asia Pacific Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 200 Asia Pacific Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 201 Asia Pacific Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 202 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 203 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 204 Asia Pacific Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 205 Asia Pacific Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 206 Asia Pacific Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 207 Asia Pacific Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 208 Asia Pacific Cardiovascular diseases Market by Country, 2018 - 2021, USD Million
TABLE 209 Asia Pacific Cardiovascular diseases Market by Country, 2022 - 2028, USD Million
TABLE 210 Asia Pacific Asthma Market by Country, 2018 - 2021, USD Million

Asia Pacific Asthma Market by Country, 2022 - 2028, USD Million 140

TABLE 211 Asia Pacific Chronic obstructive pulmonary disorders Market by Country, 2018 - 2021, USD Million
TABLE 212 Asia Pacific Chronic obstructive pulmonary disorders Market by Country, 2022 - 2028, USD Million
TABLE 213 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
TABLE 214 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
TABLE 215 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 216 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 217 Asia Pacific Chronic Disease Management Market by Country, 2018 - 2021, USD Million
TABLE 218 Asia Pacific Chronic Disease Management Market by Country, 2022 - 2028, USD Million
TABLE 219 China Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 220 China Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 221 China Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 222 China Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 223 China Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 224 China Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 225 China Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 226 China Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 227 Japan Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 228 Japan Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 229 Japan Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 230 Japan Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 231 Japan Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 232 Japan Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 233 Japan Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 234 Japan Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 235 India Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 236 India Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 237 India Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 238 India Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 239 India Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 240 India Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 241 India Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 242 India Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 243 South Korea Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 244 South Korea Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 245 South Korea Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 246 South Korea Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 247 South Korea Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 248 South Korea Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 249 South Korea Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 250 South Korea Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 251 Singapore Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 252 Singapore Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 253 Singapore Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 254 Singapore Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 255 Singapore Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 256 Singapore Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 257 Singapore Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 258 Singapore Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 259 Malaysia Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 260 Malaysia Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 261 Malaysia Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 262 Malaysia Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 263 Malaysia Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 264 Malaysia Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 265 Malaysia Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 266 Malaysia Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 267 Rest of Asia Pacific Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 268 Rest of Asia Pacific Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 269 Rest of Asia Pacific Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 270 Rest of Asia Pacific Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 271 Rest of Asia Pacific Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 272 Rest of Asia Pacific Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 273 Rest of Asia Pacific Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 274 Rest of Asia Pacific Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 275 LAMEA Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 276 LAMEA Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 277 LAMEA Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 278 LAMEA Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 279 LAMEA Solutions Market by Country, 2018 - 2021, USD Million
TABLE 280 LAMEA Solutions Market by Country, 2022 - 2028, USD Million
TABLE 281 LAMEA Services Market by Country, 2018 - 2021, USD Million
TABLE 282 LAMEA Services Market by Country, 2022 - 2028, USD Million
TABLE 283 LAMEA Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 284 LAMEA Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 285 LAMEA Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 286 LAMEA Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 287 LAMEA Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 288 LAMEA Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 289 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 290 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 291 LAMEA Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 292 LAMEA Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 293 LAMEA Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 294 LAMEA Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 295 LAMEA Cardiovascular diseases Market by Country, 2018 - 2021, USD Million
TABLE 296 LAMEA Cardiovascular diseases Market by Country, 2022 - 2028, USD Million
TABLE 297 LAMEA Asthma Market by Country, 2018 - 2021, USD Million
TABLE 298 LAMEA Asthma Market by Country, 2022 - 2028, USD Million
TABLE 299 LAMEA Chronic obstructive pulmonary disorders Market by Country, 2018 - 2021, USD Million
TABLE 300 LAMEA Chronic obstructive pulmonary disorders Market by Country, 2022 - 2028, USD Million
TABLE 301 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 302 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 303 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 304 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 305 LAMEA Chronic Disease Management Market by Country, 2018 - 2021, USD Million
TABLE 306 LAMEA Chronic Disease Management Market by Country, 2022 - 2028, USD Million
TABLE 307 Brazil Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 308 Brazil Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 309 Brazil Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 310 Brazil Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 311 Brazil Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 312 Brazil Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 313 Brazil Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 314 Brazil Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 315 Argentina Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 316 Argentina Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 317 Argentina Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 318 Argentina Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 319 Argentina Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 320 Argentina Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 321 Argentina Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 322 Argentina Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 323 UAE Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 324 UAE Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 325 UAE Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 326 UAE Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 327 UAE Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 328 UAE Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 329 UAE Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 330 UAE Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 331 Saudi Arabia Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 332 Saudi Arabia Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 333 Saudi Arabia Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 334 Saudi Arabia Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 335 Saudi Arabia Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 336 Saudi Arabia Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 337 Saudi Arabia Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 338 Saudi Arabia Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 339 South Africa Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 340 South Africa Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 341 South Africa Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 342 South Africa Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 343 South Africa Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 344 South Africa Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 345 South Africa Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 346 South Africa Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 347 Nigeria Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 348 Nigeria Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 349 Nigeria Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 350 Nigeria Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 351 Nigeria Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 352 Nigeria Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 353 Nigeria Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 354 Nigeria Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million

TABLE 355 Rest of LAMEA Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 356 Rest of LAMEA Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 357 Rest of LAMEA Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 358 Rest of LAMEA Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 359 Rest of LAMEA Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 360 Rest of LAMEA Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 361 Rest of LAMEA Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 362 Rest of LAMEA Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 363 Key Information - Infosys Limited
TABLE 364 Key Information - ExlService Holdings, Inc.
TABLE 365 Key Information - Health Catalyst, Inc.
TABLE 366 Key Information - AllScripts Healthcare Solutions, Inc.
TABLE 367 Key Information - Koninklijke Philips N.V.
TABLE 368 Key Information - Cognizant Technology Solutions Corporation
TABLE 369 Key Information - Casenet, LLC
TABLE 370 Key Information - Cedar Gate Technologies
TABLE 371 Key Information - Clinical Excellence, Inc.
TABLE 372 Key Information - Altruista Health, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep - 2022, May) Leading Players
FIG 5 Global Chronic Disease Management Market Share by Type, 2021
FIG 6 Global Chronic Disease Management Market Share by Type, 2028
FIG 7 Global Chronic Disease Management Market by Type, 2018 - 2028, USD Million
FIG 8 Global Chronic Disease Management Market Share by End User, 2021
FIG 9 Global Chronic Disease Management Market Share by End User, 2028
FIG 10 Global Chronic Disease Management Market by End User, 2018 - 2028, USD Million
FIG 11 Global Chronic Disease Management Market Share by Disease Type, 2021
FIG 12 Global Chronic Disease Management Market Share by Disease Type, 2028
FIG 13 Global Chronic Disease Management Market by Disease Type, 2018 - 2028, USD Million
FIG 14 Global Chronic Disease Management Market Share by Region, 2021
FIG 15 Global Chronic Disease Management Market Share by Region, 2028
FIG 16 Global Chronic Disease Management Market by Region, 2018 - 2028, USD Million
FIG 17 SWOT Analysis: Infosys Limited
FIG 18 Recent strategies and developments: Koninklijke Philips N.V.
FIG 19 Swot analysis: cognizant technology solutions corporation

Global Chronic Disease Management Market Size, Share & Industry Trends Analysis Report By Type (Solutions and Services), By End User (Healthcare Providers, Healthcare Payers and Others), By Disease Type, By Regional Outlook and Forecast, 2022 - 2028

Description

Table of Contents